UPST:NASDAQUpstart Holdings, Inc. Analysis
Data as of 2026-05-07 - not real-time
$29.00
Latest Price
8/10Risk
Risk Level: High
Executive Summary
Upstart is trading around $29, which sits below its 20‑day SMA of 31.84 and just above the 50‑day SMA of 28.89, with a clear support zone near 26.43 and resistance around 35.80. Technicals are mixed: the MACD shows a bearish divergence (line below signal), the RSI at 44 signals a neutral stance, and the 30‑day volatility of 68% combined with a beta of 2.9 points to pronounced price swings. Fundamentally, revenue is expanding at a robust 44.6% year‑over‑year and gross margins remain high at 82.7%, yet operating margins are razor‑thin (0.9%) and cash flow is negative, while debt‑to‑equity sits near 270, highlighting balance‑sheet strain. Valuation metrics are contradictory: a trailing P/E of 70.7 dwarfs the industry average of 16.5, suggesting overvaluation, but a forward P/E of 8.9 hints at potential earnings upside.
Recent market chatter shows a short‑term rally to the low $30s, driven by a 12.9% surge ahead of earnings and a new partnership with Justice Federal Credit Union, but the backdrop includes an emerging securities‑fraud class action alleging false AI claims. The Fear & Greed Index at 90.9 (Extreme Greed) underscores heightened investor enthusiasm, which, together with the stock’s high volatility and legal cloud, creates a volatile near‑term environment while medium‑term growth narratives remain compelling.
Recent market chatter shows a short‑term rally to the low $30s, driven by a 12.9% surge ahead of earnings and a new partnership with Justice Federal Credit Union, but the backdrop includes an emerging securities‑fraud class action alleging false AI claims. The Fear & Greed Index at 90.9 (Extreme Greed) underscores heightened investor enthusiasm, which, together with the stock’s high volatility and legal cloud, creates a volatile near‑term environment while medium‑term growth narratives remain compelling.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Bearish MACD and neutral RSI suggest limited upside
- High short‑term volatility and recent price rally
- Pending class‑action lawsuit adds legal uncertainty
Medium Term
1–3 yearsPositive
Model confidence: 7/10
Key Factors
- Strong revenue growth and high gross margins
- Forward P/E near 9 indicates earnings improvement
- Partnership expansion broadening loan origination network
Long Term
> 3 yearsNeutral
Model confidence: 6/10
Key Factors
- Elevated debt load versus cash reserves
- Potential regulatory scrutiny of AI credit models
- Sustained growth potential in AI‑driven lending if profitability improves
Key Metrics & Analysis
Financial Health
Revenue Growth44.60%
Profit Margin4.21%
P/E Ratio70.7
ROE7.01%
ROA1.77%
Debt/Equity269.84
P/B Ratio3.6
Op. Cash Flow$-267536000
Free Cash Flow$-312582368
Industry P/E16.5
Technical Analysis
TrendNeutral
RSI43.9
Support$26.43
Resistance$35.80
MA 20$31.84
MA 50$28.89
MA 200$46.26
MACDBearish
VolumeStable
Fear & Greed Index90.93
Valuation
Target Price$40.60
Upside/Downside40.00%
GradeOvervalued
TypeGrowth
Risk Assessment
Beta2.89
Volatility68.46%
Sector RiskMedium
Reg. RiskHigh
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.